Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13003189 | 0.81 | ELANE (0.37) | — | |
| SCHEMBL1758179 | 0.80 | CYP1A2 (0.38) | — | |
| SCHEMBL9181452 | 0.79 | CYP1A2 (0.40) | — | |
| SCHEMBL7128299 | 0.79 | SIGMAR1 (0.32) | — | |
| SCHEMBL15264476 | 0.77 | KMT2A (0.33) | — | |
| SCHEMBL7626957 | 0.76 | LMNA (0.39) | — | |
| SCHEMBL1324959 | 0.75 | — | — | |
| SCHEMBL17539994 | 0.74 | MAPK1 (0.40) | — | |
| SCHEMBL949470 | 0.73 | MGLL (0.50) | — | |
| SCHEMBL19619374 | 0.73 | FAAH (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227055-A1 | FUNCTIONALIZATION OF ANTIBODIES ON SENSOR STRIP FOR ORAL CANCER DETECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-10-30 | — | — | WO | claimed |
| WO-2025122328-A1 | COMPOSITIONS AND METHODS FOR VASCULAR STABILIZATION | BARD PERIPHERAL VASCULAR, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| CN-119909777-A | Photocuring micro-fluidic chip for chromatographic detection and preparation method and application thereof | 易普微流控科技(湖州)有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119500296-A | Digital micro-fluidic chip integrated with coupling active membrane and preparation method and application thereof | 浙江大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118599499-A | Cooling liquid and application thereof | 张家港迪克汽车化学品有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-117525300-A | Artificial solid electrolyte interface layer modified lithium anode material and preparation method and application thereof | 南昌航空大学 | 2024-02-06 | — | — | CN | claimed |
| WO-2025227055-A1 | FUNCTIONALIZATION OF ANTIBODIES ON SENSOR STRIP FOR ORAL CANCER DETECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025160177-A9 | COMPOSITIONS AND METHODS FOR ORGAN AND CELL TARGETED DELIVERY | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025227055-A1 | FUNCTIONALIZATION OF ANTIBODIES ON SENSOR STRIP FOR ORAL CANCER DETECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025122328-A1 | COMPOSITIONS AND METHODS FOR VASCULAR STABILIZATION | BARD PERIPHERAL VASCULAR, INC. (US) | 2025-06-12 | — | — | WO | disclosed |
| CN-119909777-A | Photocuring micro-fluidic chip for chromatographic detection and preparation method and application thereof | 易普微流控科技(湖州)有限公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025085621-A1 | MULTIVALENT APTAMER-POLYMER CONJUGATES | VALITOR, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-119500296-A | Digital micro-fluidic chip integrated with coupling active membrane and preparation method and application thereof | 浙江大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-117525300-A | Artificial solid electrolyte interface layer modified lithium anode material and preparation method and application thereof | 南昌航空大学 | 2024-02-06 | — | — | CN | disclosed |
| US-20230277525-A1 | CONJUGATE OF FUNCTIONAL DRUG AND TOLL-LIKE RECEPTOR 7 OR 8 AGONIST OF WHICH ACTIVE SITE IS TEMPORARILY INACTIVATED AND USE THEREOF | Progeneer Inc. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20230273194-A1 | NON-INVASIVE METHOD FOR DETECTION OF ENZYME ACTIVITY IN VIVO, SUBSTRATES AND A DEVICE THEREFORE | ETH Zürich (CH) | 2023-08-31 | — | — | US | disclosed |
| EP-4194010-A1 | CONJUGATE OF FUNCTIONAL DRUG AND TOLL-LIKE RECEPTOR 7 OR 8 AGONIST OF WHICH ACTIVE SITE IS TEMPORARILY INACTIVATED AND USE THEREOF | PROGENEER INC. (KR) | 2023-06-14 | — | — | EP | disclosed |
| CN-116056725-A | Conjugate of a functional drug with temporarily inactivated active site and Toll-like receptor 7 or 8 agonist and use thereof | 蛋白科技先鋒 | 2023-05-02 | — | — | CN | disclosed |
| EP-4041909-A1 | NON-INVASIVE METHOD FOR DETECTION OF ENZYME ACTIVITY IN VIVO, SUBSTRATES AND A DEVICE THEREFORE | ETH Zurich (CH) | 2022-08-17 | — | — | EP | disclosed |
| WO-2022031057-A1 | CONJUGATE OF FUNCTIONAL DRUG AND TOLL-LIKE RECEPTOR 7 OR 8 AGONIST OF WHICH ACTIVE SITE IS TEMPORARILY INACTIVATED AND USE THEREOF | 성균관대학교산학협력단 | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277525-A1 | CONJUGATE OF FUNCTIONAL DRUG AND TOLL-LIKE RECEPTOR 7 OR 8 AGONIST OF WHICH ACTIVE SITE IS TEMPORARILY INACTIVATED AND USE THEREOF | TLR8, TLR3, TLR7 | ACE 3815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.